Methotrexate

Methotrexate Reactions 1680, p224 - 2 Dec 2017 Skin necrosis and pancytopenia following methotrexate toxicity: case report A 51-year-old man developed skin necrosis and pancytopenia following methotrexate toxicity. The man had a medical history of end-stage renal disease and prurigo nodularis that had failed to respond to topical steroids and narrowband ultraviolet B phototherapy. He was started on treatment with methotrexate 7.5 mg/week [route not stated] for the persistent pruritus after discussion with the nephrologist. Two weeks later, he presented with a 2 week history of acute-onset, painful, violaceous plaques involving the bilateral medial thighs. Ill-defined, violaceous indurated plaques with central erosion and surrounding scale on the bilateral medial thighs and inguinal folds were seen on physical examination. Pancytopenia was observed on lab investigation. Basal vacuolar change with epidermal apoptosis and oedema, and a superficial dermal infiltrate consisting of lymphocytes, neutrophils and eosinophils with mild haemorrhage were seen in the histopathological examination of a punch biopsy. The man was given supportive treatment and the cell counts returned to baseline. While the cutaneous healed after discontinuation of methotrexate. Author comment: "Ours is the seventh reported case of [methotrexate]-induced cutaneous erosions in a patient without psoriasis." Merkel EA, et al. Painful, violaceous plaques in a patient with pruritus. Clinical and Experimental Dermatology 42: 931-933, No. 8, Dec 2017. Available from: URL: http://onlinelibrary.wiley.com/doi/10.1111/ced.13249/full - USA 803284376 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Methotrexate

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/methotrexate-VeuH53SwWx
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39155-4
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial